Holding(s) in Company

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ARK THERAPEUTICS GROUP PLC

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation:

 Aberforth Partners LLP

4. Full name of shareholder(s) (if different from 3.):

 Shareholder Shares

1. Aberforth Smaller Companies Trust plc 16,408,004

2. Aberforth UK Small Companies Fund 4,190,876

All shares are registered in the name of Nortrust Nominees Ltd A/c Aberfrth

5. Date of the transaction and date on which the threshold is crossed or reached:

28 July 2011

6. Date on which issuer notified:

1 August 2011

7. Threshold(s) that is/are crossed or reached:

10%

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

 Ordinary

GB0034251727

21,969,080

21,969,080

20,598,880

 N/A

20,598,880

 N/A

9.84%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/ConversionPeriod

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 N/A

 N/A

 N/A

 N/A

 N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate

Exercise/Conversionperiod

Number of votingrights instrumentrefers to

% of voting rights

 N/A

 N/A

 N/A

 N/A

 N/A

Nominal

Delta

 N/A

 N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

20,598,880

9.84%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 Held by Aberforth Partners LLP

Proxy Voting:

10. Name of the proxy holder:

 N/A

11. Number of voting rights proxy holder will cease to hold:

 N/A

12. Date on which proxy holder will cease to hold voting rights:

 N/A

13. Additional information:

14. Contact name:

 Pauline Robson, Aberforth Partners LLP

15. Contact telephone number:

 0131 220 0733